Global Chronic Lung Diseases Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 90 pages | ID: GAB4ECBCEBB7EN
QYResearch

Abstracts

This report focuses on the global Chronic Lung Diseases Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Lung Diseases Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Boehringer Ingelheim
• Novartis
• Roche
• Astellas Pharma
• Dr. Reddy’s Laboratories
• GlaxoSmithKline
• AstraZeneca
• Sanofi
• Teva Pharmaceuticals
• Asmacure Lt?e

Market segment by Type, the product can be split into

• Injection
• Capsule
• Tablet
• Other

Market segment by Application, split into

• Bronchopulmonary Dysplasia
• Asthma
• COPD
• Pulmonary Fibrosis

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Chronic Lung Diseases Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Chronic Lung Diseases Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Chronic Lung Diseases Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chronic Lung Diseases Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Chronic Lung Diseases Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Injection
  1.4.3 Capsule
  1.4.4 Tablet
  1.4.5 Other
1.5 Market by Application
  1.5.1 Global Chronic Lung Diseases Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Bronchopulmonary Dysplasia
  1.5.3 Asthma
  1.5.4 COPD
  1.5.5 Pulmonary Fibrosis
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Chronic Lung Diseases Treatment Market Perspective (2015-2026)
2.2 Chronic Lung Diseases Treatment Growth Trends by Regions
  2.2.1 Chronic Lung Diseases Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Chronic Lung Diseases Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Chronic Lung Diseases Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Chronic Lung Diseases Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Chronic Lung Diseases Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Chronic Lung Diseases Treatment Players by Market Size
  3.1.1 Global Top Chronic Lung Diseases Treatment Players by Revenue (2015-2020)
  3.1.2 Global Chronic Lung Diseases Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Chronic Lung Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chronic Lung Diseases Treatment Market Concentration Ratio
  3.2.1 Global Chronic Lung Diseases Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Chronic Lung Diseases Treatment Revenue in 2019
3.3 Chronic Lung Diseases Treatment Key Players Head office and Area Served
3.4 Key Players Chronic Lung Diseases Treatment Product Solution and Service
3.5 Date of Enter into Chronic Lung Diseases Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Chronic Lung Diseases Treatment Historic Market Size by Type (2015-2020)
4.2 Global Chronic Lung Diseases Treatment Forecasted Market Size by Type (2021-2026)

5 CHRONIC LUNG DISEASES TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Chronic Lung Diseases Treatment Market Size by Application (2015-2020)
5.2 Global Chronic Lung Diseases Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Chronic Lung Diseases Treatment Market Size (2015-2020)
6.2 Chronic Lung Diseases Treatment Key Players in North America (2019-2020)
6.3 North America Chronic Lung Diseases Treatment Market Size by Type (2015-2020)
6.4 North America Chronic Lung Diseases Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Chronic Lung Diseases Treatment Market Size (2015-2020)
7.2 Chronic Lung Diseases Treatment Key Players in Europe (2019-2020)
7.3 Europe Chronic Lung Diseases Treatment Market Size by Type (2015-2020)
7.4 Europe Chronic Lung Diseases Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Chronic Lung Diseases Treatment Market Size (2015-2020)
8.2 Chronic Lung Diseases Treatment Key Players in China (2019-2020)
8.3 China Chronic Lung Diseases Treatment Market Size by Type (2015-2020)
8.4 China Chronic Lung Diseases Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Chronic Lung Diseases Treatment Market Size (2015-2020)
9.2 Chronic Lung Diseases Treatment Key Players in Japan (2019-2020)
9.3 Japan Chronic Lung Diseases Treatment Market Size by Type (2015-2020)
9.4 Japan Chronic Lung Diseases Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Chronic Lung Diseases Treatment Market Size (2015-2020)
10.2 Chronic Lung Diseases Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chronic Lung Diseases Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Chronic Lung Diseases Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Chronic Lung Diseases Treatment Market Size (2015-2020)
11.2 Chronic Lung Diseases Treatment Key Players in India (2019-2020)
11.3 India Chronic Lung Diseases Treatment Market Size by Type (2015-2020)
11.4 India Chronic Lung Diseases Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Chronic Lung Diseases Treatment Market Size (2015-2020)
12.2 Chronic Lung Diseases Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Chronic Lung Diseases Treatment Market Size by Type (2015-2020)
12.4 Central & South America Chronic Lung Diseases Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Boehringer Ingelheim
  13.1.1 Boehringer Ingelheim Company Details
  13.1.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  13.1.3 Boehringer Ingelheim Chronic Lung Diseases Treatment Introduction
  13.1.4 Boehringer Ingelheim Revenue in Chronic Lung Diseases Treatment Business (2015-2020))
  13.1.5 Boehringer Ingelheim Recent Development
13.2 Novartis
  13.2.1 Novartis Company Details
  13.2.2 Novartis Business Overview and Its Total Revenue
  13.2.3 Novartis Chronic Lung Diseases Treatment Introduction
  13.2.4 Novartis Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
  13.2.5 Novartis Recent Development
13.3 Roche
  13.3.1 Roche Company Details
  13.3.2 Roche Business Overview and Its Total Revenue
  13.3.3 Roche Chronic Lung Diseases Treatment Introduction
  13.3.4 Roche Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
  13.3.5 Roche Recent Development
13.4 Astellas Pharma
  13.4.1 Astellas Pharma Company Details
  13.4.2 Astellas Pharma Business Overview and Its Total Revenue
  13.4.3 Astellas Pharma Chronic Lung Diseases Treatment Introduction
  13.4.4 Astellas Pharma Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
  13.4.5 Astellas Pharma Recent Development
13.5 Dr. Reddy’s Laboratories
  13.5.1 Dr. Reddy’s Laboratories Company Details
  13.5.2 Dr. Reddy’s Laboratories Business Overview and Its Total Revenue
  13.5.3 Dr. Reddy’s Laboratories Chronic Lung Diseases Treatment Introduction
  13.5.4 Dr. Reddy’s Laboratories Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
  13.5.5 Dr. Reddy’s Laboratories Recent Development
13.6 GlaxoSmithKline
  13.6.1 GlaxoSmithKline Company Details
  13.6.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.6.3 GlaxoSmithKline Chronic Lung Diseases Treatment Introduction
  13.6.4 GlaxoSmithKline Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
  13.6.5 GlaxoSmithKline Recent Development
13.7 AstraZeneca
  13.7.1 AstraZeneca Company Details
  13.7.2 AstraZeneca Business Overview and Its Total Revenue
  13.7.3 AstraZeneca Chronic Lung Diseases Treatment Introduction
  13.7.4 AstraZeneca Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
  13.7.5 AstraZeneca Recent Development
13.8 Sanofi
  13.8.1 Sanofi Company Details
  13.8.2 Sanofi Business Overview and Its Total Revenue
  13.8.3 Sanofi Chronic Lung Diseases Treatment Introduction
  13.8.4 Sanofi Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
  13.8.5 Sanofi Recent Development
13.9 Teva Pharmaceuticals
  13.9.1 Teva Pharmaceuticals Company Details
  13.9.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
  13.9.3 Teva Pharmaceuticals Chronic Lung Diseases Treatment Introduction
  13.9.4 Teva Pharmaceuticals Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
  13.9.5 Teva Pharmaceuticals Recent Development
13.10 Asmacure Lt?e
  13.10.1 Asmacure Lt?e Company Details
  13.10.2 Asmacure Lt?e Business Overview and Its Total Revenue
  13.10.3 Asmacure Lt?e Chronic Lung Diseases Treatment Introduction
  13.10.4 Asmacure Lt?e Revenue in Chronic Lung Diseases Treatment Business (2015-2020)
  13.10.5 Asmacure Lt?e Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Chronic Lung Diseases Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Chronic Lung Diseases Treatment Revenue
Table 3. Ranking of Global Top Chronic Lung Diseases Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chronic Lung Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Injection
Table 6. Key Players of Capsule
Table 7. Key Players of Tablet
Table 8. Key Players of Other
Table 9. Global Chronic Lung Diseases Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Chronic Lung Diseases Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Chronic Lung Diseases Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Chronic Lung Diseases Treatment Market Share by Regions (2015-2020)
Table 13. Global Chronic Lung Diseases Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Chronic Lung Diseases Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Chronic Lung Diseases Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Chronic Lung Diseases Treatment Players
Table 20. Global Chronic Lung Diseases Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Chronic Lung Diseases Treatment Market Share by Players (2015-2020)
Table 22. Global Top Chronic Lung Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Lung Diseases Treatment as of 2019)
Table 23. Global Chronic Lung Diseases Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Chronic Lung Diseases Treatment Product Solution and Service
Table 26. Date of Enter into Chronic Lung Diseases Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Chronic Lung Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Chronic Lung Diseases Treatment Market Size Share by Type (2015-2020)
Table 30. Global Chronic Lung Diseases Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Chronic Lung Diseases Treatment Market Size Share by Application (2015-2020)
Table 32. Global Chronic Lung Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Chronic Lung Diseases Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Chronic Lung Diseases Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Chronic Lung Diseases Treatment Market Share (2019-2020)
Table 36. North America Chronic Lung Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Chronic Lung Diseases Treatment Market Share by Type (2015-2020)
Table 38. North America Chronic Lung Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Chronic Lung Diseases Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Chronic Lung Diseases Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Chronic Lung Diseases Treatment Market Share (2019-2020)
Table 42. Europe Chronic Lung Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Chronic Lung Diseases Treatment Market Share by Type (2015-2020)
Table 44. Europe Chronic Lung Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Chronic Lung Diseases Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Chronic Lung Diseases Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Chronic Lung Diseases Treatment Market Share (2019-2020)
Table 48. China Chronic Lung Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Chronic Lung Diseases Treatment Market Share by Type (2015-2020)
Table 50. China Chronic Lung Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Chronic Lung Diseases Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Chronic Lung Diseases Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Chronic Lung Diseases Treatment Market Share (2019-2020)
Table 54. Japan Chronic Lung Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Chronic Lung Diseases Treatment Market Share by Type (2015-2020)
Table 56. Japan Chronic Lung Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Chronic Lung Diseases Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Chronic Lung Diseases Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Chronic Lung Diseases Treatment Market Share (2019-2020)
Table 60. Southeast Asia Chronic Lung Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Chronic Lung Diseases Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Chronic Lung Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Chronic Lung Diseases Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Chronic Lung Diseases Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Chronic Lung Diseases Treatment Market Share (2019-2020)
Table 66. India Chronic Lung Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Chronic Lung Diseases Treatment Market Share by Type (2015-2020)
Table 68. India Chronic Lung Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Chronic Lung Diseases Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Chronic Lung Diseases Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Chronic Lung Diseases Treatment Market Share (2019-2020)
Table 72. Central & South America Chronic Lung Diseases Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Chronic Lung Diseases Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Chronic Lung Diseases Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Chronic Lung Diseases Treatment Market Share by Application (2015-2020)
Table 76. Boehringer Ingelheim Company Details
Table 77. Boehringer Ingelheim Business Overview
Table 78. Boehringer Ingelheim Product
Table 79. Boehringer Ingelheim Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (Million US$)
Table 80. Boehringer Ingelheim Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Product
Table 84. Novartis Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (Million US$)
Table 85. Novartis Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Product
Table 89. Roche Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (Million US$)
Table 90. Roche Recent Development
Table 91. Astellas Pharma Company Details
Table 92. Astellas Pharma Business Overview
Table 93. Astellas Pharma Product
Table 94. Astellas Pharma Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (Million US$)
Table 95. Astellas Pharma Recent Development
Table 96. Dr. Reddy’s Laboratories Company Details
Table 97. Dr. Reddy’s Laboratories Business Overview
Table 98. Dr. Reddy’s Laboratories Product
Table 99. Dr. Reddy’s Laboratories Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (Million US$)
Table 100. Dr. Reddy’s Laboratories Recent Development
Table 101. GlaxoSmithKline Company Details
Table 102. GlaxoSmithKline Business Overview
Table 103. GlaxoSmithKline Product
Table 104. GlaxoSmithKline Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (Million US$)
Table 105. GlaxoSmithKline Recent Development
Table 106. AstraZeneca Company Details
Table 107. AstraZeneca Business Overview
Table 108. AstraZeneca Product
Table 109. AstraZeneca Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (Million US$)
Table 110. AstraZeneca Recent Development
Table 111. Sanofi Business Overview
Table 112. Sanofi Product
Table 113. Sanofi Company Details
Table 114. Sanofi Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (Million US$)
Table 115. Sanofi Recent Development
Table 116. Teva Pharmaceuticals Company Details
Table 117. Teva Pharmaceuticals Business Overview
Table 118. Teva Pharmaceuticals Product
Table 119. Teva Pharmaceuticals Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (Million US$)
Table 120. Teva Pharmaceuticals Recent Development
Table 121. Asmacure Lt?e Company Details
Table 122. Asmacure Lt?e Business Overview
Table 123. Asmacure Lt?e Product
Table 124. Asmacure Lt?e Revenue in Chronic Lung Diseases Treatment Business (2015-2020) (Million US$)
Table 125. Asmacure Lt?e Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Chronic Lung Diseases Treatment Market Share by Type: 2020 VS 2026
Figure 2. Injection Features
Figure 3. Capsule Features
Figure 4. Tablet Features
Figure 5. Other Features
Figure 6. Global Chronic Lung Diseases Treatment Market Share by Application: 2020 VS 2026
Figure 7. Bronchopulmonary Dysplasia Case Studies
Figure 8. Asthma Case Studies
Figure 9. COPD Case Studies
Figure 10. Pulmonary Fibrosis Case Studies
Figure 11. Chronic Lung Diseases Treatment Report Years Considered
Figure 12. Global Chronic Lung Diseases Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Chronic Lung Diseases Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Chronic Lung Diseases Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Chronic Lung Diseases Treatment Market Share by Players in 2019
Figure 17. Global Top Chronic Lung Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Lung Diseases Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Chronic Lung Diseases Treatment Revenue in 2019
Figure 19. North America Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Chronic Lung Diseases Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Boehringer Ingelheim Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 28. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Novartis Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 30. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Roche Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 32. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Astellas Pharma Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 34. Dr. Reddy’s Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Dr. Reddy’s Laboratories Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 36. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. GlaxoSmithKline Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 38. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. AstraZeneca Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 40. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Sanofi Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 42. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Teva Pharmaceuticals Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 44. Asmacure Lt?e Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Asmacure Lt?e Revenue Growth Rate in Chronic Lung Diseases Treatment Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed